Literature DB >> 4417700

Gentamicin pharmacokinetics during hemodialysis.

T G Christopher, D Korn, A D Blair, A W Forrey, M A O'Neill, R E Cutler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4417700     DOI: 10.1038/ki.1974.75

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  12 in total

1.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Inactivation of gentamicin by penicillins in patients with renal failure.

Authors:  F R Ervin; W E Bullock; C E Nuttall
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

4.  Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis.

Authors:  L Regeur; H Colding; H Jensen; J P Kampmann
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

6.  Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure.

Authors:  D C Blair; D O Duggan; E T Schroeder
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

7.  Pharmacokinetics of gentamicin in hemodialysis patients: a comparative study between diabetic and non-diabetic patients.

Authors:  Mohammed A Al-Homrany; Yacoub M Irshaid; Assem K El Sherif; Haider A Omar
Journal:  Int Urol Nephrol       Date:  2008-09-03       Impact factor: 2.370

8.  Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing.

Authors:  Kevin M Sowinski; Stephanie J Magner; Aroonrut Lucksiri; Meri K Scott; Richard J Hamburger; Bruce A Mueller
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 9.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

10.  Antibiotic blood concentrations in patients successfully treated with tobramycin.

Authors:  M Fiala; S N Chatterjee
Journal:  Postgrad Med J       Date:  1981-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.